Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis
Open Access
- 1 November 2005
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 2 (11) , e333
- https://doi.org/10.1371/journal.pmed.0020333
Abstract
Leber congenital amaurosis (LCA), a heterogeneous early-onset retinal dystrophy, accounts for ~15% of inherited congenital blindness. One cause of LCA is loss of the enzyme lecithin:retinol acyl transferase (LRAT), which is required for regeneration of the visual photopigment in the retina. An animal model of LCA, the Lrat−/− mouse, recapitulates clinical features of the human disease. Here, we report that two interventions—intraocular gene therapy and oral pharmacologic treatment with novel retinoid compounds—each restore retinal function to Lrat−/− mice. Gene therapy using intraocular injection of recombinant adeno-associated virus carrying the Lrat gene successfully restored electroretinographic responses to ~50% of wild-type levels (p < 0.05 versus wild-type and knockout controls), and pupillary light responses (PLRs) of Lrat−/− mice increased ~2.5 log units (p < 0.05). Pharmacological intervention with orally administered pro-drugs 9-cis-retinyl acetate and 9-cis-retinyl succinate (which chemically bypass the LRAT-catalyzed step in chromophore regeneration) also caused long-lasting restoration of retinal function in LRAT-deficient mice and increased ERG response from ~5% of wild-type levels in Lrat−/− mice to ~50% of wild-type levels in treated Lrat−/− mice (p < 0.05 versus wild-type and knockout controls). The interventions produced markedly increased levels of visual pigment from undetectable levels to 600 pmoles per eye in retinoid treated mice, and ~1,000-fold improvements in PLR and electroretinogram sensitivity. The techniques were complementary when combined. Intraocular gene therapy and pharmacologic bypass provide highly effective and complementary means for restoring retinal function in this animal model of human hereditary blindness. These complementary methods offer hope of developing treatment to restore vision in humans with certain forms of hereditary congenital blindness.Keywords
This publication has 58 references indexed in Scilit:
- RetinosomesThe Journal of cell biology, 2004
- Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its RegulationJournal of Biological Chemistry, 2004
- Lecithin-retinol Acyltransferase Is Essential for Accumulation of All-trans-Retinyl Esters in the Eye and in the LiverJournal of Biological Chemistry, 2004
- Selective Transmission of Single Photon Responses by Saturation at the Rod-to-Rod Bipolar SynapseNeuron, 2004
- Noninvasive two-photon imaging reveals retinyl ester storage structures in the eyeThe Journal of cell biology, 2004
- Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosisNature Genetics, 2003
- Retinol-Binding Protein-Deficient Mice: Biochemical Basis for Impaired VisionBiochemistry, 2002
- Gene therapy for retinal and choroidal diseasesExpert Opinion on Biological Therapy, 2002
- Night blindness in Sorsby's fundus dystrophy reversed by vitamin ANature Genetics, 1995
- Light-induced axial and radial shrinkage effects and changes of the refractive index in isolated bovine rod outer segments and disc vesiclesEuropean Biophysics Journal, 1981